Digestive System Carcinoma — Trials

Digestive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,540 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,123
Recruiting: 1,216
Ph III recruiting: 129
Growth YoY: +14.1%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (884)

clinicaltrialsPublishedShowing 101–150 of 549 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02990481	A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors	completed	Phase 1	38	Toray Industries, IncINDUSTRY	2	Apr 16, 2025	clinicaltrials
NCT06345001	A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers	completed	Phase 1	14	BayerINDUSTRY	1	Apr 13, 2025	clinicaltrials